Mental health platform Savonix raised $1.5 million in a seed round, led by RoundGlass Partners, with participation from Kickstart Seed Fund, BMNT Capital, and strategic San Francisco-based angel investors Bandel Carano and Connecticut based, Ed Glassmeyer, among others.

The company’s solution was built on the findings of decades of research including hundreds of peer review published papers. The Savonix assessment platform evaluates core domains of cognition in just half an hour all from a smartphone or tablet, and is touted as the only mobile evidence-based digital neuro-cognitive assessment and health platform to deliver clinical grade results and insights.

“Savonix is founded on the knowledge that evidence-based digital neuro-assessment positively impacts the lives and health of individuals and organizations,” said Dr. Mylea Charvat, CEO and Founder of Savonix. “We know these cognitive assessments work, they’ve simply been unavailable behind the walls of academia or trapped within decades old structures that are expensive, cumbersome and inaccessible. Savonix is going to liberate these tools and make evidence-based cognitive testing available and affordable to anyone.”

Savonix’s founding team includes CEO and Founder, Mylea Charvat, a translational neuroscientist who completed her Ph.D. fellowship in clinical neuroscience at Stanford School of Medicine and Vice President of Product, Devin Seto, former Executive Producer at Zynga and Lucas Arts.

The mobile mental health space is heating up with the day. Some of the other companies fighting in this space include Joyable, Lantern, Lyra Health, SelfEcho, Talkspace, PsyInnovations and Ginger.io.